News

Date

Title

  • Mar 18, 2026

    Newsletter – Q1 2026

  • Feb 24, 2026

    Complete Genomics Highlights DNBSEQ-T7+ at AGBT 2026, Expanding High-Throughput Sequencing Capability 

  • Feb 23, 2026

    Complete Genomics Enters Definitive Agreement to Be Acquired by Swiss Rockets AG  

  • Nov 11, 2025

    Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform for Comprehensive Genomic Profiling at AMP 2025

  • Nov 11, 2025

    Complete Genomics Highlights Clinical Research Sequencing Solutions and Partnerships at AMP 2025

  • Oct 14, 2025

    Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025

  • Oct 13, 2025

    Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG

  • Apr 28, 2025

    Complete Genomics, Velsera partner to integrate sequencing and analysis platforms

  • Apr 15, 2025

    Complete Genomics Names Four Winners of Spatial Xcellerator Grant Program

  • Mar 25, 2025

    Complete Genomics Announces Partnership with BioTuring and the Go Optical STOmics Microscope

  • Mar 25, 2025

    Complete Genomics Announces Commercial Partnership with Human Cell Atlas to Offer its Members Stereo-seq Spatial Transcriptomics at NextGen Omics & Spatial Biology Conference

  • Feb 23, 2025

    Complete Genomics unveils DNBSEQ-T1+ and DNBSEQ-E25 Flash at AGBT 2025 General Meeting

  • Jan 9, 2025

    2024 Year in Review: Complete Genomics’ Innovations and Impact

  • Dec 17, 2024

    Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program

  • Nov 20, 2024

    Complete Genomics announces mpox virus amplicon sequencing panel at AMP